pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Preclinical
    ABO-505
    Optic Neuropathy$ABEO ABEONA THERAPEUTICS INC.
  • Phase 2
    ABP-745
    Gouty Arthritis (Gout) Atom Therapeutics Co Ltd
  • Phase 1
    ABS-0871
    Charcot-Marie-Tooth Disease Type II Actio Biosciences Inc
  • Phase 2
← prev
page 48 of 231
next →
131
Pain89
Neurology1
ABS-201
Androgenic Alopecia
Almirall SA
  • Phase 1
    ABSK-112
    Non-Small Cell Lung Cancer Abbisko Therapeutics Co Ltd
  • Phase 1
    ABSK-121
    Bile Duct Cancer (Cholangiocarcinoma) Abbisko Therapeutics Co Ltd
  • Phase 2
    ABSK-141
    Solid Tumor Abbisko Therapeutics Co Ltd
  • Phase 1
    ABX-1100
    Pompe Disease Aro Biotherapeutics Co
  • Preclinical
    ABX-919
    Atopic Dermatitis (Atopic Eczema) Abrax Japan
  • Phase 1
    AC-0676
    Diffuse Large B-Cell Lymphoma Accutar Biotechnology Inc
  • Phase 1
    AC-0699
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Accutar Biotechnology Inc
  • Preclinical
    AC-1
    Traumatic Brain Injury AivoCode LLP
  • Preclinical
    ACAR-198
    Autoimmune Disorders AbelZeta Inc
  • Phase 2
    ACD-440
    Neuropathic Pain (Neuralgia) AlzeCure Pharma AB
  • Phase 2
    ACDN-01
    Juvenile Macular Degeneration (Stargardt Disease) Ascidian Therapeutics Inc
  • Phase 1
    ACE-1334
    Systemic Sclerosis (Scleroderma)$MRK Merck & Co., Inc.
  • Phase 1
    ACE-1702
    Solid Tumor Acepodia Inc
  • Phase 2
    ACE-1831
    Immunoglobulin G4-Related Disease (IgG4-RD) Acepodia Inc
  • Phase 1
    ACE-2016
    Solid Tumor Acepodia Inc
  • Phase 1
    ACE-232
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Acerand Therapeutics
  • ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG
    ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG (ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG TABLETS)
    no indication TARO
  • ACETAMINOPHEN AND CODEINE
    ACETAMINOPHEN AND CODEINE
    no indication AMNEAL PHARMS NY
  • Phase 2
    ACI-24060
    Alzheimer's Disease$ACIU AC Immune SA
  • Phase 1
    ACLX-001
    Refractory Multiple Myeloma$ACLX Arcellx, Inc.
  • Preclinical
    ACM-002
    Amyotrophic Lateral Sclerosis Actimed Therapeutics Ltd
  • Phase 2
    ACP-01
    Vescell
    Chronic Stable Angina Hemostemix Inc
  • Phase 2
    ACP-017
    Cutaneous Squamous Cell Carcinoma (cSCC) Ascendis Pharma AS
  • Phase 1
    ACR-2316
    Endometrial Cancer$ACRV Acrivon Therapeutics, Inc.
  • Phase 2
    ACT-001
    Pediatric Diffuse Intrinsic Pontine Glioma Accendatech Co Ltd
  • Phase 1
    ACT-101
    Myasthenia Gravis Alpha Cancer Technologies Inc